microdose oral semaglutide Microdosing Compounded Microdosing GLP-1 and GLP-2 medications

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) and glucose dependent insulinotropic polypeptide (GIP) are incretins which share similarity in terms of structure and function but exhibit diverse properties and functions

Since it is to be injected subcutaneously (into the fatty tissue layer directly below the skin), the first dose should ideally be administered by a healthcare professional

Because the mechanisms are completely different, a poor response to phentermine does not predict a poor response to GLP-1 medications

With microdosing, the initial dose may be as low as 0.05 milligrams weekly, with a slower increase in the dose than usual. Full doses can range all the way up to 2.4 milligrams per week, depending on the brand and the specific needs of the person being prescribed the medication